01172017Headline:

New York, New York

HomeNew YorkNew York

Dori Milner

Xarelto Mass Tort Adopts MDL Bellwether Selection Process

In January 2015, Philadelphia Court of Common Pleas Judge Kevin Dougherty created a mass tort docket for all state-filed Xarelto lawsuits. At that time, about 75 cases were centralized in the same court, with plaintiffs alleging excessive bleeding injuries after […]

Roopal Luhana

Number of PPI Lawsuits Increasing in Federal Courts

The number of lawsuits filed against the makers of heartburn drugs like Nexium and Prilosec continues to increase. These drugs belong to a class of medications called “proton pump inhibitors (PPIs)”. They reduce the production of stomach acid and are […]

Roopal Luhana

Illinois Man Seeks $10 Million in Nexium Chronic Kidney Disease Lawsuit

On August 26, 2016, an Illinois man filed a new Nexium lawsuit in the U.S. District Court for the Eastern District of New York. He names Nexium manufacturer AstraZeneca as defendant, and claims that after he took the heartburn drug, […]

Roopal Luhana

Xarelto MDL Getting Closer to Choosing Final 4 Bellwether Trial Cases

The U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Xarelto lawsuits into one court in the Eastern District of Louisiana in December 2014. Since then, both sides have been working toward selecting a few key cases to go […]

Roopal Luhana

Louisiana Court Chooses 4 Xarelto Cases for Bellwether Trials

In December 2014, all federally filed Xarelto lawsuits were consolidated into one court in the Eastern District of Louisiana. Now, Judge Eldon Fallon, who has been overseeing the proceedings, has selected four cases to serve as the first bellwether cases. […]

Roopal Luhana

Editorial in Pharmaceutical Journal Calls for an End to PPI Overprescribing

A new editorial published in Pharmaceutical Journal by Dr. Daniel Marks, Clinical Pharmacologist at University College London Hospital, calls for limiting inappropriate prescribing of proton pump inhibitors (PPIs) , like Nexium and Prilosec, because of the risk of adverse effects. […]

Roopal Luhana

FDA Delays Approval of Potential Xarelto Antidote

One of the main safety concerns associated with the blood-thinner Xarelto (rivaroxaban) and other similar anticoagulant drugs is that there is no readily available antidote. Patients taking warfarin, the leading anticoagulant for decades, who experience excessive bleeding events, can be […]

Kendra Goldhirsch

Heartburn Drugs, When Combined with Other Drugs, May Worsen Kidney Damage

Recent studies have linked popular heartburn drugs like Prevacid and Nexium—so called “proton-pump inhibitors” or PPIs—to side effects like chronic kidney disease, bone fractures, and dependency. Now, a new study published in the International Journal of Basic & Clinical Pharmacology […]

Kendra Goldhirsch

Onglyza Still Excluded from Express Scripts 2017 Formulary

Express Scripts continues to exclude diabetes drug Onglyza from its preferred formulary, listing it as an exclusion for 2017. The prescription benefit plan provider first dropped the medication from its list last year, when it announced that it would no […]

Kendra Goldhirsch

Case Study Indicates Heartburn Drugs May Cause Rhabdomyolysis

Proton pump inhibitors (PPIs) like Nexium and Prilosec have been linked in recent studies to a number of potentially dangerous side effects, including bone fractures and chronic kidney disease. A new case study, however, suggests that there may be other […]